Femtech At Work

It started with a lone tampon rolling around at the bottom of a handbag. That was the moment,
Mia Klitsas, the Co-founder of Moxie, Australia's progressive period care brand on a mission to make women feel genuinely seen through products that are functional, beautiful, and built around real needs that have been overlooked for far too long.
In this episode, Mia takes us behind twenty-one years of building a brand from the ground up, bootstrapped, battle-tested, and unapologetically focused on women. From cracking major retail at 22 with nothing but cold calls and conviction, to developing Australia's first purpose-built pad for endometriosis, there is a lot in this conversation that goes well beyond period care.
If you are building something, selling something, or simply trying to understand what it really takes to create a product women actually need, the answers are in here. Let’s dive in!

Key Takeaways:
Find out how a tampon rolling around in a handbag sparked a business idea that a 21-year-old turned into a launch in just six months with nothing but guts, cold calls, and a dog-with-a-bone attitude
Discover why Moxie calls itself progressive period care and what that actually means when it comes to the way they talk about women's bodies, periods, and pain
Learn what Mia personally uncovered when she sat down with 43 people living with endometriosis, and why what she heard completely changed how Moxie thinks about product development
Find out what Australia's first purpose-built pad for endometriosis actually does differently
Find out why Mia believes the future of women's health innovation isn't just about building products for women and the two words that she thinks should sit at the centre of every founder's process
Find out why Mia thinks most people building in women's health are still getting it fundamentally wrong and the uncomfortable truth she's not afraid to say out loud

Resources:
Mia Klitsas: LinkedIn
Moxie: Instagram | TikTok | YouTube
Moxie: Website
Maaike Steinebach: LinkedIn
Website Femtech Future: https://www.femtechfuture.com
Instagram Femtech Future: @femtech_future

Mia didn't wait for permission to change the conversation around periods, she just started having it. Loudly, honestly, and without apology. And in doing so, she built something that millions of women around the world didn't even know they were waiting for. That's what happens when you stop designing around what's comfortable and start designing around what's real.
If this episode resonated with you, share it with a woman in your life who deserves to feel seen in her health. Like it, leave a review, and help us keep amplifying the founders who are quietly and not so quietly changing the face of women's health. See you next week for another episode of Femtech At Work.

What if the data collected during your pregnancy could predict and even prevent - a heart attack, a stroke, or dementia decades later? That's not a distant vision. That's exactly what HeraMed is building right now.
Anoushka Gungadin's path to CEO of HeraMed is anything but straight from growing up in Mauritius, to a decade in China, to building a leadership practice in Australia. And it's that exact breadth of experience that shapes the way she thinks about women's health. Because in her world, one size has never, and should never, fit all.
This is a conversation about technology, equity, and what it truly looks like to build healthcare that's designed around the woman not the other way around.

Key Takeaways:
Find out how a girl from Mauritius who detoured through China and corporate boardrooms ended up leading one of the most exciting companies in women's health
Discover how HeraMed quietly grew from a single device into a full women's health platform and what that journey reveals about where personalized care is actually headed
Learn the link your doctor probably never mentioned, what happens in your pregnancy and what it could mean for your heart, your brain, and your body decades down the line
Find out why AI is failing women 60% of the time right now and how HeraMed is tackling a bias that most of the health tech world isn't even willing to admit exists
Discover what a "maternity desert" really means and why the scale of the problem in the US is what brought an Australian company all the way across the Pacific
Learn the one thing that makes or breaks clinician buy-in for health tech innovation and why it has nothing to do with how impressive your technology is
Find out what Anoushka thinks is quietly getting in the way of real progress in Australia's femtech space and why she believes the industry's biggest unlock isn't funding, it's each other
Discover why being the only ASX-listed femtech company is not the win it sounds like and what it actually tells us about how far women's health investment still has to go

Resources:
Anoushka Gungadin: LinkedIn
HeraMed: LinkedIn
HeraMed: hera-med.com
Maaike Steinebach: LinkedIn
Website Femtech Future: https://www.femtechfuture.com
Instagram Femtech Future: @femtech_future

Anoushka isn't just building a platform, she's building a future where a woman's health data actually follows her, protects her, and works for her at every stage of life. That vision is rare. And it deserves to be heard.
If this episode resonated with you, share it with a woman in your life who deserves better from her healthcare. Like it, leave a review, and help us keep putting these conversations in front of the people who need them most. Thank you, and see you next week for another episode of Femtech At Work.

Millions of women rely on hormone therapy patches to survive menopause, yet Big Pharma has essentially decided that fixing the global patch shortage isn't profitable enough. What happens when the system fails women, and two midlife founders decide to rewrite the rules of healthcare themselves?
In this episode, Maaike sits down with Johanna Wicks, co-founder of Lorai Health, to expose the frustrating reality behind the global patch shortage and the regulatory question marks surrounding decades-old formulas. Johanna shares her own harrowing battle with undiagnosed perimenopause and reveals Lorai's ambitious, unconventional two-patch strategy to disrupt the market, navigate the brutal world of female-founder funding, and secure a shocking quarter-million-dollar lifeline.
If you are ready for a masterclass in science, fury, and pure resilience, this is an episode you cannot afford to miss. Tune in now to find out exactly how Lorai Health plans to get patches back on the shelves in record time.

Key Takeaways:
Find out what two years of unexplained symptoms, repeated doctor visits, and a diagnosis that should have come much sooner taught Johanna and how it completely rewrote the path her career would take
Discover the uncomfortable truth behind why menopause hormone therapy patches are in chronic global shortage and why the pharmaceutical companies that could solve it keep looking the other way
Learn what Laorai Health's two-patch strategy actually involves and why the timeline for getting a better patch into women's hands is shorter than you might expect
Find out why manufacturing a hormone therapy patch is far more complicated than it sounds, and how a surprisingly small number of facilities worldwide are even equipped to do it
Learn what Johanna and her co-founder Raisa experienced when they took their vision to venture capital and why the reality of female founders in the funding world is even more sobering than the statistics suggest
Find out how a GoFundMe, a Channel Nine news story, and a stranger on the Gold Coast set off a chain of events that resulted in a quarter-million-dollar donation and what it signals about where true support for women's health actually comes from
Discover why Australia's sophisticated investor rules may be quietly shutting the very women who believe in Lorai Health out of the opportunity to back it and why Johanna thinks the whole system needs a rethink

What happens when you combine decades of medical sales expertise with a refusal to accept the status quo? You get Amelia Dickinson, the founder of Capture Care.
In this beautifully raw conversation, Amelia opens up about the painful turning points that led her here. From navigating three redundancies and systemic harassment to witnessing the silent health struggles women face in midlife. Together, we will explore why medical data is empty without real empathy, how small daily choices (like a single glass of wine) can dictate the boundary between brain fog and clarity, and why she is fiercely dedicated to funding free legal aid for women falling through the cracks. This is more than a business profile; it’s a vital blueprint for women's survival and success in the modern world.

Key Takeaways:
Find out why a stable career in Big Pharma isn't as secure as it looks, and what specific "accumulation of experiences" forced Amelia to stop playing by the industry's rules?
Learn the secret to slashing patient medication drop-off rates from 50% to just 14% using a model that prioritizes human connection over automated alerts
Understand why monitoring your health through "snapshots" like annual blood tests is failing you, and how continuous data can reveal what’s actually happening to your cortisol and hormones in real-time
Discover how "Preventative Remote Patient Monitoring" is filling the dangerous gap between your annual doctor appointments
Find out why women in midlife are 10x more likely to develop autoimmune issues and how real-time data can stop a crisis before it starts
Learn the specific "Health Summary" strategy that ensures you are never rushed during a 15-minute GP consult again
Discover why Amelia believes that a normal reaction to an abnormal situation is the most important thing a woman in perimenopause needs to hear

Resources:
Amelia Dickison: LinkedIn
CaptureCare Digitals: LinkedIn
CaptureCare Digitals: Instagram
CaptureCare Digitals: https://capturecare.com.au/
Maaike Steinebach: LinkedIn
Website Femtech Future: https://www.femtechfuture.com
Instagram Femtech Future: @femtech_future

Amelia’s story reminds us that the most powerful innovations don't come from a lab, they come from a "lived experience" that says enough is enough. From the trenches of medical sales to the boardrooms of Singapore, she is proving that when women are cared for, the entire economy rises.
If this episode moved you, don't keep it to yourself. Like, share, and leave a review to help us amplify the voices of founders who are literally saving lives. Your engagement is the fuel that keeps this movement growing.
Thank you, and see you next week for another episode of FemTech at Work.

Vaginal health is central to a woman’s life, from her first period to her last hot flush – yet it remains one of the most dismissed, misunderstood and under-researched areas of healthcare. In this powerful conversation, we sit down with Sarah Galloy, founder of Pinc Wellness, to unpack the reality behind recurrent BV, UTIs, thrush and the emotional toll of not being believed.
If you’ve ever been dismissed by a doctor, struggled with recurring infections, or simply felt you “should know more” about your own body, this episode will leave you informed, validated and ready to join a bigger movement for change.

Key Takeaways:
Find out how Sarah’s personal battle with recurrent BV, UTIs and thrush pushed her from repeated medical gaslighting to founding Pinc Wellness in the first place
Discover what bacterial vaginosis (BV) actually is, how the vaginal microbiome and pH shifts trigger it, and why so many women have it without obvious symptoms
Understand how male partners can carry BV-causing bacteria like Gardnerella without symptoms, and why treating only the woman often leads to endless recurrence
Learn why antibiotics alone rarely solve recurrent vaginal infections, and how rebuilding a healthy vaginal microbiome with probiotics and acidity support can change everything
Find out which Pink Wellness products women are turning to most like vaginal probiotics, gentle washes with boric acid and vulva oils and what specific problems they help address
Discover how social media censorship of words like “vagina” and “vulva” shapes what women see and learn online, and why educational femtech content gets punished while pure product posts thrive
Find out what Sarah’s new Pink Bloom platform will offer from vaginal microbiome testing to telehealth with gynecologists, naturopaths and sexologists across every life stage
Discover what needs to change in healthcare, education and at home so that parents can confidently teach their daughters about vaginal microbiome and intimate wellness from day one

Resources:
Sarah Galloy: LinkedIn
Pinc Wellness: LinkedIn | https://www.instagram.com/pincwellness/
Pinc Wellness: https://pincwellness.com/
Maaike Steinebach LinkedIn
Website Femtech Future: https://www.femtechfuture.com
Instagram Femtech Future: @femtech_future

In a world where vaginal health is still treated as niche, shameful or “too much for the workplace,” conversations like this one are how change begins. Sarah’s journey from gaslighting to founding Pink Wellness and now building Pink Bloom proves that women’s intimate health is not a side topic; it is central to our physical, mental and sexual wellbeing.
If this episode resonated with you, don’t keep it to yourself. Share it with a friend who needs to hear she’s not alone. Like this episode, leave a review so more listeners can find these stories, and help us push vaginal health and femtech into the mainstream. See you on our next episode